Subscribe To
DRMA / Dermata Therapeutics (DRMA) Stock: Why The Price Substantially Fell Today
Content Topics
Public
Joint
Stock
Company
Slavneft
Yaroslavnefteorgsintez
Jnosp
Me
Dermata
Therapeutics
drma
Stock
Substantially
DRMA
DRMA News
By Accesswire
June 13, 2023
Dermata Therapeutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
SAN DIEGO, CA / ACCESSWIRE / June 13, 2023 / Dermata Therapeutics, Inc. (NASDAQ:DRMA, DRMAW) ("Dermata" or the "Company"), a clinical-stage biotechnol more_horizontal
By Zacks Investment Research
April 21, 2023
Dermata (DRMA) Gains on Positive FDA Response for Acne Candidate
Dermata (DRMA) gains on positive FDA response for the further development of DMT310 for treating severe to moderate acne. more_horizontal
By InvestorPlace
April 20, 2023
Why Is Dermata Therapeutics (DRMA) Stock Up 22% Today?
Dermata Therapeutics (NASDAQ: DRMA ) stock is on the rise Thursday following an update concerning its moderate-to-severe acne treatment. The big news more_horizontal
By PennyStocks
January 3, 2023
Trading Penny Stocks in the New Year? 3 Tips
Which penny stocks are you buying this year? The post Trading Penny Stocks in the New Year? more_horizontal
By Benzinga
February 7, 2022
Dermata Therapeutics Shares Plunge 20% Premarket: What Investors Need To Know
Dermata Therapeutics Inc DRMA has requested the FDA to waive the requirements to complete a 90-day dermal minipig study and a standard dermal phar more_horizontal
By Benzinga
February 7, 2022
Dermata Therapeutics Shares Plunge 20% Premarket: What Investors Need To Know
Dermata Therapeutics Inc DRMA has requested the FDA to waive the requirements to complete a 90-day dermal minipig study and a standard dermal phar more_horizontal
By Benzinga
February 7, 2022
Dermata Therapeutics Shares Plunge 20% Premarket: What Investors Need To Know
Dermata Therapeutics Inc DRMA has requested the FDA to waive the requirements to complete a 90-day dermal minipig study and a standard dermal phar more_horizontal
By Pulse2
February 7, 2022
Dermata Therapeutics (DRMA) Stock: Why The Price Substantially Fell Today
The stock price of Dermata Therapeutics Inc (NASDAQ: DRMA) fell by over 15% pre-market today. This is why it happened. more_horizontal